Main Navigation

Advancing Patient Care

Langford Vets is passionately committed to excellence in animal health and being at the forefront of clinical care including advancing knowledge through research. Langford Vets undertakes world leading clinical research that is internationally disseminated, not only improving animal health and welfare locally, but also throughout the world.

Certifications

Clinical Research News

(Including funding success)

July 2024

Kennel Club - Runner Up Award

Yeonsoo Choi an undergraduate student at Bristol Veterinary School was awarded runner up in the Kennel Club student inspiration award ICHA - Kennel Club Charitable Trust for her project researching acute kidney injury working with our Head of Renal Medicine, Natalie Finch.

Companion BSAVA - Highly Commended Award

India Law a recent Bristol Veterinary School graduate was awarded highly commended in the Companion | BSAVA  student project abstract competition for her project entitled ‘Fibroblast growth factor-23 (FGF-23) in cardiorenal syndrome in cats with chronic kidney disease’ undertaken under the supervision of Dr Natalie Finch and Prof Melanie Hezzell.

Latest news & stories  Our Clinical Research Updates

Recent Publications

Choose one of the business areas below to see recent publications from each team:

Actively Recruiting Studies

Defining the immune response to canine osteosarcoma

Canine osteosarcoma is an aggressive bone cancer, predominantly affecting young, large breed dogs. Bone cancers occur when normal bone cells become damaged and divide uncontrollably, forming a mass of growing cells, associated with a local tumour environment. Osteosarcoma is associated with poor survival (50% at 1-year in canines) and there have been no significant advances in treatment or survival in the last five decades. Most dogs with osteosarcoma have tumours on their legs, therefore amputation, sometimes with post-operative chemotherapy, is the recommended treatment. After amputation, the tumour is analysed to confirm a diagnosis of osteosarcoma, and then disposed of in clinical waste. We intend to use waste tumour samples to study osteosarcoma and develop more effective treatment options.

Immunotherapy is a type of cancer treatment which uses drugs to encourage the immune system to fight cancer. In many cancers, immune cells are switched off and become inert when they enter the tumour, owing to molecules released within the local tumour environment. Blocking immunosuppressive pathways within tumours can reinvigorate the immune system and allow tumour killing. There are no immunotherapies available for canine osteosarcoma at the moment, because the immune response to osteosarcoma is not well understood.

We will stain samples of canine osteosarcoma with fluorescent markers and use a microscope to identify immune cells, extract cells of interest, and analyse their genetic material. Together, these findings will tell us what happens to immune cells when they enter osteosarcoma masses, and help us to identify immunotherapies that can be used in canine osteosarcoma. Together with the VetCompass(TM) programme at the Royal Veterinary College, we also carry out research into the genetics of canine osteosarcoma, looking at which breeds are most at risk with the aim of improving early detection and intervention strategies.

The work will be carried out by Dr Grace Edmunds, a member of our internal medicine team with a PhD in cancer immunology. Grace collaborates with researchers at Cardiff University, the University of Sheffield and the Royal Veterinary College.

We are recruiting osteosarcoma cases, please contact sah@langfordvets.co.uk to refer a case or enquire about enrolling your dog in our studies.

Mitral Valve Clinic

The Mitral Valve Clinic at Langford Vets is run by Prof Melanie Hezzell, a specialist veterinary cardiologist with a PhD in the epidemiology of canine myxomatous mitral valve disease. The Mitral Valve Clinic is a prospective, longitudinal cohort study of canine myxomatous mitral valve disease. Participating dogs typically attend the clinic every 6 months. At each visit they undergo comprehensive monitoring of their disease, including a full clinical examination, blood pressure measurement, an ECG, an ultrasound of their heart and blood and urine tests. The clinic aims to collect information about how the disease develops and progresses over time, and the factors that determine why some dogs have mild, non-progressive disease while others have a severe, rapidly progressive phenotype.

The clinic aims to benefit both current patients, by providing heavily subsidised expert monitoring for dogs with mitral valve disease and future patients, by investigating how and why this disease develops and progresses. Our goal is to develop new treatments and therapies that will improve the dogs’ lives. The clinic also nurtures the next generation of veterinary clinical researchers by providing opportunities for veterinary surgeons to undertake Masters by Research and PhD studentships.

For more information, please contact Melanie Hezzell: mh16511@bristol.ac.uk or Langford Vets Small Animal Hospital reception 0117 394 0513.

Send an email

Langford Vets Clinical Research Fund

Langford Vets has a clinical research fund to support research projects undertaken by Langford Vets employees and University of Bristol employees who work within Langford Vets clinics.

Here are some of the latest projects that have been funded:

Feline Infectious Peritonitis (FIP)

Use of machine learning in the diagnosis of feline infectious peritonitis

Principal Investigator: Dr Emi Barker

A collaborative study with Ohio State University, University of California Davis, and University of Sydney.

Feline infectious peritonitis (FIP) is a fatal disease of cats. Diagnosis can be challenging; therefore the use of artificial intelligence (AI) is being explored as a tool for facilitating in diagnosis. A form of AI, machine learning (ML), has the potential to predict a diagnosis of FIP and potentially response to treatment more accurately than an experienced clinician.

However, in order for ML to generate accurate algorithms – and subsequently test the accuracy of those algorithms – a large set of clinical and clinicopathological data from cats with a diagnosis of FIP and similar cats with an alternate diagnosis is required.

As part of an international collaborative study (PIs Dr Samantha Evans at Ohio State University, and Dr Krystle Reagan at University of California Davis – veterinary specialist with a track record of investigating FIP and ML) clinical history and clinicopathological results for cats diagnosed with FIP and signalment-matched (age / breed / sex) cats without FIP will be reviewed and shared anonymously. These cats will be retrospectively recruited via the Langford Vets Small Animal Hospital, Langford Vets Small Animal Practice, and University of Bristol Feline Infectious Peritonitis Biobank.

These data would be used to determine the accuracy of ML in the diagnosis of FIP from clinical and routine clinicopathological data.

Does a non-steroidal...

Does a non-steroidal anti-inflammatory drug (NSAID) combined with paracetamol give a greater opioid sparing effect in the peri-operative period than an NSAID alone in dogs undergoing tibial plateau levelling osteotomy (TPLO)?

Principal Investigator: Robin Stallard

This study aims to assess the opioid sparing effect of intravenous paracetamol in dogs undergoing a routine orthopaedic surgery. Clients presenting their dogs to the hospital for unilateral tibial plateau levelling osteotomy can opt in to the study. There will be a test group receiving IV paracetamol and a control group that does not. The dogs will all receive a standard anaesthetic/surgical management protocol with the only difference being the study group will also receive 10mg/kg paracetamol IV every 8 hours starting at the time of induction of anaesthesia. The dogs will be regularly assessed for pain after the surgery and additional analgesia (methadone 0.1mg/kg IV) will be given if required. The total dose of methadone required will be compared between groups to assess the opioid sparing effect of 10mg/kg paracetamol IV.

The impact of Simini antiseptic lavage...

The impact of Simini antiseptic lavage solution on Pseudomonas biofilm on three different orthopaedic implant materials.

Principal Investigator: Daniel Lomas

Simini is a lavage solution that is used intra-operatively to reduce biofilm on orthopaedic implants in the presence of infection or in surgeries with a higher expected infection rate e.g revision surgery. The solution does not contain antibiotics and is a combination of active ingredients. It therefore aims to reduce the use of antibiotics in orthopaedic surgery. In addition, biofilms are inherently resistant to penetration by antibiotics. Simini has been theorised to have a synergistic effect with antibiotic therapy by weakening or disrupting the bacterial biofilm.

The effectiveness of this solution has not been demonstrated on pseudomonas biofilms which is commonly isolated bacteria from veterinary orthopaedic infections and tends to form implant biofilms easily. In addition, the effectiveness on 316L stainless steel, which is the most used material in veterinary orthopaedic implants, has not been investigated.

Small Animal Hospital Inset Day Research Stream

opens in new window